Results of immunotherapy for patients with unexplained secondary recurrent abortions.

[1]  L. Fainboim,et al.  Is the Paternal Mononuclear Cells’ Immunization a Successful Treatment for Recurrent Spontaneous Abortion? , 2000, American journal of reproductive immunology.

[2]  C. Ober,et al.  Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial , 1999, The Lancet.

[3]  R. Raghupathy Th1-type immunity is incompatible with successful pregnancy. , 1997, Immunology today.

[4]  Eran Gazit,et al.  Allogenic leukocyte immunization after five or more miscarriages. Recurrent Miscarriage Immunotherapy Trialists Group. , 1997, Human reproduction.

[5]  M. Clerici,et al.  Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy , 1996, Clinical and experimental immunology.

[6]  O. Christiansen,et al.  Worldwide Collaborative Observational Study and Meta‐Analysis on Allogenic Leukocyte Immunotherapy for Recurrent Spontaneous Abortion 1 , 1994 .

[7]  T. Mosmann,et al.  Synthesis of T helper 2-type cytokines at the maternal-fetal interface. , 1993, Journal of immunology.

[8]  T. Mosmann,et al.  Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? , 1993, Immunology today.

[9]  R. Simes,et al.  Treatment of Recurrent Spontaneous Abortion by Immunization With Paternal Lymphocytes: Results of a Controlled Trial , 1993, American journal of reproductive immunology.

[10]  H. Ueda,et al.  Is an Additional Vaccination Necessary for a Successful Second Pregnancy in Unexplained Recurrent Aborters Who Were Successfully Immunized With Their Husband's Lymphocytes Before the First Pregnancy? , 1993, American journal of reproductive immunology.

[11]  D. Branch,et al.  Interpretation of blocking activity in maternal serum depends on the equation used for calculation of mixed lymphocyte culture results , 1990, Clinical and experimental immunology.

[12]  S. Takeuchi,et al.  Result of Immunotherapy on Patients With Unexplained Recurrent Abortion: A Beneficial Treatment for Patients With Negative Blocking Antibodies , 1990, American journal of reproductive immunology.

[13]  T. Wegmann,et al.  Placental immunotrophism: maternal T cells enhance placental growth and function. , 1987, American journal of reproductive immunology and microbiology : AJRIM.

[14]  A. Lindholm,et al.  Transfusions of leukocyte‐rich erythrocyte concentrates: A successful treatment in selected cases of habitual abortion , 1987 .

[15]  A. Lindholm,et al.  Transfusions of leukocyte‐rich erythrocyte concentrates: A successful treatment in selected cases of habitual abortion , 1986, American journal of obstetrics and gynecology.

[16]  S. Takeuchi,et al.  Production of blocking antibodies by vaccination with husband's lymphocytes in unexplained recurrent aborters: the role in successful pregnancy. , 1986, American journal of reproductive immunology and microbiology : AJRIM.

[17]  J. Mowbray,et al.  CONTROLLED TRIAL OF TREATMENT OF RECURRENT SPONTANEOUS ABORTION BY IMMUNISATION WITH PATERNAL CELLS , 1985, The Lancet.

[18]  P. Johnson,et al.  Immunogenetic studies of recurrent spontaneous abortions in humans. , 1985, Experimental and clinical immunogenetics.

[19]  A. Beer,et al.  Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. , 1981, American journal of obstetrics and gynecology.

[20]  W. Faulk,et al.  PREVENTION OF RECURRENT ABORTION WITH LEUCOCYTE TRANSFUSIONS , 1981, The Lancet.

[21]  Hassold Tj A cytogenetic study of repeated spontaneous abortions. , 1980 .

[22]  T. Hassold A cytogenetic study of repeated spontaneous abortions. , 1980, American journal of human genetics.